NCT04960514View on ClinicalTrials.gov

Prospective Decision Impact Trial of KidneyIntelX

Active, not recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2026

Conditions
Diabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2Chronic Kidney Disease, Stage 3 (Moderate)
Interventions
DIAGNOSTIC_TEST

KidneyIntelX

KidneyIntelX is a blood-based clinical diagnostic tool that assesses the risk of progressive kidney function decline in chronic kidney disease patients with type 2 diabetes.

Trial Locations (1)

27104

Atrium Health Wake Forest Baptist - Family Medicine - Piedmont Plaza, Winston-Salem

All Listed Sponsors
lead

Renalytix AI, Inc.

INDUSTRY